Announcement on Resolutions of the 11th Meeting of the 2nd Board of Directors
Securities code: 603334 Securities abbreviation: Fengbei Biotechnology Announcement number: 2026-028 Suzhou Fengbei Biotechnology Co., Ltd.
Announcement of Resolutions of the Eleventh Meeting of the Second Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
1. Convening of board of directors meetings
The 11th meeting of the second board of directors of Suzhou Fengbei Biotechnology Co., Ltd. (hereinafter referred to as the "Company") was held on August 20, 2026 by on-site and communication means. The meeting notice was notified to all directors by email and other means of communication on August 10, 2026. The meeting was convened and chaired by Mr. Pingyuan, the chairman of the company. Nine directors were supposed to attend the meeting, but actually attended. The company's senior management also attended the meeting. The convening, holding and voting procedures of this meeting complied with the provisions of the Company Law and other laws and regulations, normative documents and the Articles of Association.
2. Review status of board of directors meeting
(1) Consideration and adoption of the “Proposal on the 2026 Semi-annual Report and its Summary”
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors.
For details, please refer to the company's "2026 Semi-Annual Report" and "2026 Semi-Annual Report Summary" published on the website of the Shanghai Stock Exchange (www.sse.com.cn) and the company's designated disclosure media on the same day.
(2) Consider and approve the "Proposal on the Special Report on the Deposit, Management and Actual Use of Funds Raised in the Half-Year of 2026"
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors.
For details, please refer to the "Special Report on the Storage, Management and Actual Use of Funds Raised in the Half-Year of 2026" published by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) and the company's designated disclosure media on the same day.
(3) Consideration and approval of the "Proposal on Developing and Revising Part of the Company's Governance System"
In order to further standardize corporate governance and establish and improve the company's internal governance system, in accordance with relevant regulations such as the Company Law and the Code of Governance for Listed Companies, and in light of the actual situation of the company, the board of directors agreed to formulate a "Financial Assistance Management System" and revise the "Working Rules for the General Manager", "Working Rules for the Board Secretary", "Working Rules for the Audit Committee of the Board of Directors", "Insider Information Insider Registration and Management System", "Management System for the Company's Shares Held by Directors and Senior Management and Changes", "Subsidiary Management System" and "Information Disclosure Suspension and Exemption Business Management System".
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
For details, please refer to the relevant systems published by the company on the Shanghai Stock Exchange website (www.sse.com.cn) and the company’s designated disclosure media on the same day.
Announcement is hereby made.
Board of Directors of Suzhou Fengbei Biotechnology Co., Ltd.
August 24, 2026